Total Funding: 371217878.0
Headquarters: Vancouver, British Columbia, Canada
Funding Status: IPO
Employee Number: 101-250
Estimated Revenue: $10M to $50M
Last Funding Type: Series B
Last Funding Date: 2020-05-27
Investors Number: 12.0
Founded Date: 2012-01-01
Industry: Early Drug Development